Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest.

Yoshiba S, Ito D, Nagumo T, Shirota T, Hatori M, Shintani S.

Oral Oncol. 2009 Feb;45(2):109-15. doi: 10.1016/j.oraloncology.2008.04.002. Epub 2008 Aug 16.

PMID:
18710819
2.

[Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].

Wu XA, Sun Y, Fan QX, Wang LX, Wang RL, Zhang L.

Zhonghua Yi Xue Za Zhi. 2007 Oct 9;87(37):2640-4. Chinese.

PMID:
18162154
3.

Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.

Shimanishi M, Ogi K, Sogabe Y, Kaneko T, Dehari H, Miyazaki A, Hiratsuka H.

J Oral Pathol Med. 2013 May;42(5):382-8. doi: 10.1111/jop.12028. Epub 2012 Dec 10.

PMID:
23227892
4.

Pseudomonas aeruginosa exotoxin A reduces chemoresistance of oral squamous carcinoma cell via inhibition of heat shock proteins 70 (HSP70).

Park SR, Lee KD, Kim UK, Gil YG, Oh KS, Park BS, Kim GC.

Yonsei Med J. 2010 Sep;51(5):708-16. doi: 10.3349/ymj.2010.51.5.708.

5.

Effect of 5-fluorouracil on G1 phase cell cycle regulation in oral cancer cell lines.

Li MH, Ito D, Sanada M, Odani T, Hatori M, Iwase M, Nagumo M.

Oral Oncol. 2004 Jan;40(1):63-70.

PMID:
14662417
6.

Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha.

Huang L, Ao Q, Zhang Q, Yang X, Xing H, Li F, Chen G, Zhou J, Wang S, Xu G, Meng L, Lu Y, Ma D.

J Cancer Res Clin Oncol. 2010 Mar;136(3):447-56. doi: 10.1007/s00432-009-0675-4. Epub 2009 Sep 16.

PMID:
19760195
7.

Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial to mesenchymal transition changes.

Harada K, Ferdous T, Ueyama Y.

Int J Oncol. 2014 Apr;44(4):1302-8. doi: 10.3892/ijo.2014.2270. Epub 2014 Jan 21.

PMID:
24452635
8.

Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.

Harada K, Ferdous T, Harada T, Ueyama Y.

Int J Oncol. 2016 Jul;49(1):276-84. doi: 10.3892/ijo.2016.3523. Epub 2016 May 16.

PMID:
27210058
9.

Terbinafine inhibits oral squamous cell carcinoma growth through anti-cancer cell proliferation and anti-angiogenesis.

Chien MH, Lee TS, Kao C, Yang SF, Lee WS.

Mol Carcinog. 2012 May;51(5):389-99. doi: 10.1002/mc.20800. Epub 2011 May 11.

PMID:
21563217
10.

Cell-cycle distribution and Thymidilate Synthatase (TS) expression correlate with 5-FU resistance in head and neck carcinoma cells.

Ijichi K, Adachi M, Ogawa T, Hasegawa Y, Murakami S.

Anticancer Res. 2014 Jun;34(6):2907-11.

PMID:
24922653
11.

UCN-01 (7-hydroxystaurosporine) induces apoptosis and G1 arrest of both primary and metastatic oral cancer cell lines in vitro.

Otsubo A, Bhawal UK, Nomura Y, Mitani Y, Ozawa K, Kuniyasu H, Sugiyama M.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103(3):391-7. Epub 2006 Jul 11.

PMID:
17321452
12.
13.
14.

Antitumor activity of suberoylanilide hydroxamic acid against human oral squamous cell carcinoma cell lines in vitro and in vivo.

Nagumo T, Takaoka S, Yoshiba S, Ohashi M, Shirota T, Hatori M, Isobe T, Tachikawa T, Shintani S.

Oral Oncol. 2009 Sep;45(9):766-70. doi: 10.1016/j.oraloncology.2008.11.009. Epub 2009 Jan 20.

PMID:
19157955
15.

The human HECA interacts with cyclins and CDKs to antagonize Wnt-mediated proliferation and chemoresistance of head and neck cancer cells.

Dowejko A, Bauer R, Bauer K, Müller-Richter UD, Reichert TE.

Exp Cell Res. 2012 Mar 10;318(5):489-99. doi: 10.1016/j.yexcr.2011.11.004. Epub 2011 Nov 10.

PMID:
22100912
16.

Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells.

Nakagawa Y, Nakayama H, Nagata M, Yoshida R, Kawahara K, Hirosue A, Tanaka T, Yuno A, Matsuoka Y, Kojima T, Yoshitake Y, Hiraki A, Shinohara M.

Int J Oncol. 2014 Apr;44(4):1376-84. doi: 10.3892/ijo.2014.2265. Epub 2014 Jan 21.

PMID:
24452447
17.

5-fluorouracil mediates apoptosis and G1/S arrest in laryngeal squamous cell carcinoma via a p53-independent pathway.

Liu HC, Chen GG, Vlantis AC, Leung BC, Tong MC, van Hasselt CA.

Cancer J. 2006 Nov-Dec;12(6):482-93.

PMID:
17207318
18.

Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism.

Xuan Y, Hur H, Ham IH, Yun J, Lee JY, Shim W, Kim YB, Lee G, Han SU, Cho YK.

Exp Cell Res. 2014 Feb 15;321(2):219-30. doi: 10.1016/j.yexcr.2013.12.009. Epub 2013 Dec 14.

PMID:
24342832
19.

Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.

Su L, Wang Y, Xiao M, Lin Y, Yu L.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):484-91. doi: 10.1016/j.tripleo.2010.04.009.

PMID:
20868995
20.

Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.

McGinn CJ, Pestalozzi BC, Drake JC, Glennon MC, Kunugi K, Otterson G, Allegra CJ, Johnston PG, Kinsella TJ.

Cancer J. 2000 Jul-Aug;6(4):234-42.

PMID:
11038143

Supplemental Content

Support Center